Need for early diagnosis & effective management to improve quality of healthcare

The Indian healthcare system is witnessing a shift from communicable diseases (CDs) to more Non-Communicable Diseases (NCDs). The prevalence of NCDs are reaching alarming levels, with 2.7 million cases of cardiovascular diseases, 62 million of diabetes, 1.5 million of stroke, 30 million chronic respiratory diseases and 1 million incident of cancer cases. India’s SDG commitment towards NCDs is “by 2030 reduce one third premature mortality from NCDs through prevention and treatment and promote mental health and well-being”.

Technology and competence for NCD care are concentrated in hospitals, making it harder to access for rural dwellers. Being an out-of-pocket market, prices is another constraining factor. The lack of patient data, poor protocol administration and low quality compliance lead to treatment of symptoms instead of root-cause prevention. Between 50%-60% of diabetics remain ‘undiagnosed’.

In order to save lives and reduce life cycle costs, it is essential to screen patients, diagnose diseases early and provide effective disease management. Digital tools such as IoT, big data and AI in health care will enable remote and efficient screening, classification and diagnosis of large populations, along with effective and safe patient path planning and follow-up.

There is a requirement to establish an incubation of providers with diverse expertise who can bring relevant, meaningful innovative solutions such as:

  1. Remote/Portable screening methods for early detection of NCDs 
  2. Precise, handy point of care diagnostic solutions that will ease detection and monitoring
  3. Digital tools/techniques that enable efficient health record capture, patient monitoring, treatment pathway solutions and adherence trackers

Join us in creating an ecosystem of synergistically working, evidence based solutions that foster holistic disease management, reducing healthcare burden and saving lives. 

Call for collaboration to accelerate innovative technologies for sustainable healthcare

In-line with the spirit of the Indo-Swedish Innovation partnership, we invite innovative companies (including start-ups, small and medium size companies), leading researchers and disruptive entrepreneurs to work with AstraZeneca in creating accessible and affordable healthcare in India. The challenge is coordinated by The Swedish Trade and Invest Council,in collaboration with AGNIi - Invest India and ATAL Innovation Mission – NITI Aayog.



Who are we looking for?

This challenge is open for companies working for either diabetes, cardio vascular disease, cancer/ oncology or respiratory, with expertise in the following areas: 

  1. Digital Solutions: Leveraging IoT to improve access, collect data and remote care to reduce staff burden, use big data analytic to make informed treatment decisions 
  2. Diagnosis: Utilizing advanced diagnostic technologies for remote and precise disease diagnosis
  3. Digital Devices: Combining drugs with digital devices for better treatment, better disease management services at affordable costs 

The solution could be hardware, software or application; however the solution should create accessibility for the rural area; and be affordable and scalable in terms of bringing down the cost of treatment. Sought solutions should have aspects of “frugal innovation”, be easily scalable, interact with the Indian government systems and understand the complexity of Indian health system at different government levels, clinics and stakeholders. IOT, AI and VR will form the basis of bringing paradigm shift in healthcare delivery, along with medical devices and efficient management – to find beyond the pill solutions.

What can you expect as a partner?

Applicants are screened and selected on their merits. Successful candidates will be:

  • Invited to present their ideas at an India-Sweden workshop on innovation in Healthcare
    • Innovation workshop connected to the challenge will be held in Delhi, Q1 2019 
  • Offered mentoring program from AstraZeneca
    • AstraZeneca will provide critical technical and commercial guidance
    • Face to face/virtual meetings on a quarterly/half-yearly basis
  • Provided a platform for showcasing innovations at AstraZeneca’s global innovation hubs 
  • Provided assistance to map and apply for funding for further market oriented R&D

UNNATI Healthcare 2.0

21 February 2019

The Taj Mahal Hotel
1 Man singh Road, New Delhi

Application open until 1 January 2019




Industry partners



In collaboration with





Contact us

Address: c/o Embassy of Sweden, Nyaya Marg, Chanakyapuri, 110 021 New Delhi, India
Phone: +91 (0)11 4606 7100